SEC Form 4 · accession 0001193125-26-279726
Atea Pharmaceuticals, Inc. · AVIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Franklin M Berger
Director
Period of report
Jun 18, 2026
Accepted (ET)
Jun 23, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001593899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 18, 2026 | M | 29,600 | $0.00 | A | 536,097 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jun 18, 2026 | M | 29,600 | D | — | — | Common Stock | 29,600 | 0 | D |
| Restricted Stock UnitsF1,F3 | — | Jun 18, 2026 | A | 26,700 | A | — | — | Common Stock | 26,700 | 26,700 | D |
| Stock Option (Right to Buy)F4 | $4.36 | Jun 18, 2026 | A | 37,700 | A | — | Jun 17, 2036 | Common Stock | 37,700 | 37,700 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- F2The RSUs vested in full on June 18, 2026.
- F3The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
- F4The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.